Abbott Laboratories's total assets for Q3 2025 were $84.18B, an increase of 0.22% from the previous quarter. ABT total liabilities were $32.92B for the fiscal quarter, a -0.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.